+

WO2008011387A3 - Préparation d'un composant de globule rouge pour un contrôle hématologique - Google Patents

Préparation d'un composant de globule rouge pour un contrôle hématologique Download PDF

Info

Publication number
WO2008011387A3
WO2008011387A3 PCT/US2007/073625 US2007073625W WO2008011387A3 WO 2008011387 A3 WO2008011387 A3 WO 2008011387A3 US 2007073625 W US2007073625 W US 2007073625W WO 2008011387 A3 WO2008011387 A3 WO 2008011387A3
Authority
WO
WIPO (PCT)
Prior art keywords
red blood
blood cell
preparation
cell component
blood cells
Prior art date
Application number
PCT/US2007/073625
Other languages
English (en)
Other versions
WO2008011387B1 (fr
WO2008011387A2 (fr
Inventor
Franklin J Carver
Lorraine Granier
Original Assignee
Bio Rad Laboratories
Franklin J Carver
Lorraine Granier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Rad Laboratories, Franklin J Carver, Lorraine Granier filed Critical Bio Rad Laboratories
Priority to JP2009520945A priority Critical patent/JP4898915B2/ja
Priority to CN2007800272625A priority patent/CN101490545B/zh
Priority to AU2007275410A priority patent/AU2007275410B2/en
Priority to EP07812988.9A priority patent/EP2710367B1/fr
Priority to CA2657165A priority patent/CA2657165C/fr
Publication of WO2008011387A2 publication Critical patent/WO2008011387A2/fr
Publication of WO2008011387A3 publication Critical patent/WO2008011387A3/fr
Publication of WO2008011387B1 publication Critical patent/WO2008011387B1/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/101666—Particle count or volume standard or control [e.g., platelet count standards, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/20—Oxygen containing
    • Y10T436/200833—Carbonyl, ether, aldehyde or ketone containing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/2525—Stabilizing or preserving

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L'invention concerne des globules rouges d'un vertébré qui sont traitées pour en faire des composants efficaces d'un contrôle hématologique, contrôle que l'on peut alors utiliser pour détecter tous les composants de cellules sanguines, y compris les globules blancs et les plaquettes. Le traitement comprend l'utilisation d'un fixatif dans des conditions limitées de concentration et d'exposition, et les globules rouges résultantes sont stables mais lysables dans un instrument hématologique et leur tendance à former des particules est réduite.
PCT/US2007/073625 2006-07-17 2007-07-16 Préparation d'un composant de globule rouge pour un contrôle hématologique WO2008011387A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2009520945A JP4898915B2 (ja) 2006-07-17 2007-07-16 血液学的対照用の赤血球成分の調製
CN2007800272625A CN101490545B (zh) 2006-07-17 2007-07-16 制备用作血液学对照品的红细胞组分
AU2007275410A AU2007275410B2 (en) 2006-07-17 2007-07-16 Preparation of a red blood cell component for a hematology control
EP07812988.9A EP2710367B1 (fr) 2006-07-17 2007-07-16 Préparation d'un composant de globule rouge pour un contrôle hématologique
CA2657165A CA2657165C (fr) 2006-07-17 2007-07-16 Preparation d'un composant de globule rouge pour un controle hematologique

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US80758506P 2006-07-17 2006-07-17
US60/807,585 2006-07-17
US11/777,864 US7482161B2 (en) 2006-07-17 2007-07-13 Preparation of a red blood cell component for a hematology control
US11/777,864 2007-07-13

Publications (3)

Publication Number Publication Date
WO2008011387A2 WO2008011387A2 (fr) 2008-01-24
WO2008011387A3 true WO2008011387A3 (fr) 2008-07-24
WO2008011387B1 WO2008011387B1 (fr) 2008-09-18

Family

ID=38957532

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/073625 WO2008011387A2 (fr) 2006-07-17 2007-07-16 Préparation d'un composant de globule rouge pour un contrôle hématologique

Country Status (7)

Country Link
US (1) US7482161B2 (fr)
EP (1) EP2710367B1 (fr)
JP (1) JP4898915B2 (fr)
CN (2) CN102213725B (fr)
AU (1) AU2007275410B2 (fr)
CA (1) CA2657165C (fr)
WO (1) WO2008011387A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7618821B2 (en) * 2007-04-13 2009-11-17 Streck, Inc. Simulated blood components and methods
US20100086962A1 (en) * 2008-10-08 2010-04-08 Streck, Inc. Hematology controls and methods
US8114580B2 (en) * 2009-01-13 2012-02-14 Bio-Rad Laboratories, Inc. Simulation of normal fresh blood platelets for reference control
KR102010094B1 (ko) * 2011-04-28 2019-08-12 베크만 컬터, 인코포레이티드 연장된 안정성을 가지는 혈액학 대조 조성물
CN103336110B (zh) * 2013-06-18 2014-08-13 南京普朗医疗设备有限公司 一种全血质控物及其制备方法
CN105717312B (zh) * 2014-12-04 2018-07-06 深圳迈瑞生物医疗电子股份有限公司 一种红细胞模拟粒子、其制备方法以及含该模拟粒子的质控物或校准物
CN107615062B (zh) 2015-02-09 2022-03-18 弹弓生物科学公司 具有可调光学性质的水凝胶颗粒以及使用其的方法
JP6791121B2 (ja) * 2015-03-13 2020-11-25 ソニー株式会社 電気的特性測定用試料及び電気的特性測定方法並びに電気的特性測定装置
CN110770587B (zh) * 2017-05-08 2023-10-20 拜克门寇尔特公司 用于裂解红细胞的组合物和方法
JP2023511132A (ja) 2020-01-24 2023-03-16 スリングショット バイオサイエンシーズ， インコーポレイテッド 細胞様較正粒子のための組成物および方法
WO2021226036A1 (fr) 2020-05-04 2021-11-11 Slingshot Biosciences, Inc. Compositions et méthodes de codage optique passif de dosages multiplexés
WO2023076629A1 (fr) 2021-10-29 2023-05-04 Slingshot Biosciences, Inc. Particules d'hydrogel en tant que cellules nourricières et en tant que cellules présentatrices d'antigènes synthétiques
AU2023280490A1 (en) 2022-06-02 2024-12-05 Slingshot Biosciences, Inc. Apoptotic cell mimic
WO2024092161A2 (fr) 2022-10-26 2024-05-02 Slingshot Biosciences, Inc. Particules synthétiques réglables en taille ayant des propriétés optiques réglables et leurs procédés d'utilisation pour l'activation de cellules immunitaires

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1509539A (en) * 1974-04-21 1978-05-04 Wales Sec Of State For Whole blood standards for use in haematology
US4579824A (en) * 1983-05-18 1986-04-01 Louderback Allan Lee Hematology control
US4777139A (en) * 1987-06-25 1988-10-11 Fisher Scientific Company Hematology control or calibrator with red cell components of enhanced stability
US20050227359A1 (en) * 2004-04-07 2005-10-13 Beckman Coulter, Inc. Reference control containing a nucleated red blood cell component
US20060194191A1 (en) * 2005-02-25 2006-08-31 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Processing method for the long-term stabilization of biological red blood cell volume

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3873467A (en) * 1974-02-01 1975-03-25 United Medical Lab Inc Hematologic reference control
US3973913A (en) * 1976-01-29 1976-08-10 Louderback Allan Lee Blood control standard
US5429797A (en) * 1993-11-10 1995-07-04 Camiener; Gerald W. Safe dialdehydes useful as decontaminants, fixatives, preservatives and embalming agents
US6146901A (en) * 1997-06-16 2000-11-14 Hematronix, Inc. Composition for manipulating optical and electrical properties of particles to achieve target values for such properties and methods for using the composition
US5994139A (en) * 1998-04-07 1999-11-30 Coulter International Corp. Stable hematology control composition and method of use
US6221668B1 (en) * 1999-08-20 2001-04-24 Streck Laboratories, Inc. Hematology control and system for multi-parameter hematology measurements
US6653063B2 (en) * 2000-06-12 2003-11-25 Hematronix, Inc. Hematology composition using preserved white blood cells in combination with source particles to simulate native white blood cells and method of making same
AUPQ886100A0 (en) * 2000-07-19 2000-08-10 Biotron Limited Diagnostic test
KR100459644B1 (ko) * 2001-03-31 2004-12-03 제노백(주) 혈액 여과지에서의 효소면역측정법을 이용한셀룰로플라스민 농도 측정 방법 및 이 방법을 이용한윌슨병 스크리닝 검사용 키트와 진단 시약

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1509539A (en) * 1974-04-21 1978-05-04 Wales Sec Of State For Whole blood standards for use in haematology
US4579824A (en) * 1983-05-18 1986-04-01 Louderback Allan Lee Hematology control
US4777139A (en) * 1987-06-25 1988-10-11 Fisher Scientific Company Hematology control or calibrator with red cell components of enhanced stability
US20050227359A1 (en) * 2004-04-07 2005-10-13 Beckman Coulter, Inc. Reference control containing a nucleated red blood cell component
US20060194191A1 (en) * 2005-02-25 2006-08-31 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Processing method for the long-term stabilization of biological red blood cell volume

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP2710367A4 *

Also Published As

Publication number Publication date
CN101490545A (zh) 2009-07-22
CA2657165A1 (fr) 2008-01-24
EP2710367A2 (fr) 2014-03-26
WO2008011387B1 (fr) 2008-09-18
AU2007275410A1 (en) 2008-01-24
WO2008011387A2 (fr) 2008-01-24
CN102213725B (zh) 2015-01-21
CA2657165C (fr) 2014-04-08
CN102213725A (zh) 2011-10-12
JP4898915B2 (ja) 2012-03-21
EP2710367A4 (fr) 2014-03-26
US20080026468A1 (en) 2008-01-31
CN101490545B (zh) 2011-09-14
JP2009544041A (ja) 2009-12-10
US7482161B2 (en) 2009-01-27
AU2007275410B2 (en) 2014-08-07
EP2710367B1 (fr) 2016-03-16

Similar Documents

Publication Publication Date Title
WO2008011387A3 (fr) Préparation d'un composant de globule rouge pour un contrôle hématologique
EP1978361A3 (fr) Procédé pour effectuer la correction de polarisation d'analyse sanguine du glucose utilisant une concentration d'hémoglobine comme déterminé par un système de combinaison A1C glucose-hémoglobine et dispositifs pour celui-ci
ATE554777T1 (de) Zubereitung eines nukleierten zell- und/oder thrombozyten-konzentrats aus einer physiologischen lösung
ATE551348T1 (de) Poröser und kristalliner hybridfestkörper zur aufnahme und freigabe eines gases von biologischem interesse
GB2453068A (en) Novel hepatocyte-like cells and hepatoblast-like cells derived from hbs cells
WO2006020060A3 (fr) Composes de liaison aux proteines iap
WO2010135437A3 (fr) Canule à plusieurs lumières
BR112012031071A2 (pt) 8-proteínas de ligação à il-1
WO2007149724A3 (fr) Substats destinées à effectuer des réactions d'analyse
ATE363657T1 (de) Hämatologische kontrolle und system für hämatologische viel-parameter-messungen
CA2863012A1 (fr) Procede et dispositif de mesure d'informations sanguines
UA97234C2 (ru) Раствор хлорида натрия для восстановления влагосодержания композиции лиофилизированного фактора ix
WO2005021706A3 (fr) Administration de composes avec des cellules sanguines rehydratees
DE602006015727D1 (de) Verfahren zur messung von plasmaspiegeln von pentraxin ptx3
WO2007136641A3 (fr) Procédés de traitement de pertes de sang aiguës
WO2006135811A3 (fr) Procede d'utilisation d'antagonistes de zonuline aux fins de prevention de la perte des cellules pancreatiques ou aux fins de regeneration de celles-ci
Abdel-Moneim et al. Correlation between oxidative stress and hematological profile abnormalities in diabetic nephropathy
WO2006107421A3 (fr) Preparation d'analogues de plaquettes
GB0501352D0 (en) Use of glycosylation modulators in combination with membrane fusion inhibitors for treatment of infections caused by viruses bearing glycosylated envelope
TW200605872A (en) Alcohol-metabolism enhancing composition and ingesta containing the same
WO2012053823A3 (fr) Protéine hybride présentant une activité du facteur ix
DK1660115T3 (da) Farmaceutisk kombination af G-CSF og PLGF anvendelig til blodstamceller
WO2006089074A3 (fr) Methode et appareil d'analyse de fluides corporels
MX340107B (es) Metodo de medicion inmunologica para precurso de peptido que libera gastrina.
EP3948302A4 (fr) Procédé et dispositif de mesure de la concentration de fibrinogène dans des échantillons de sang

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200780027262.5

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07812988

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 24/MUMNP/2009

Country of ref document: IN

ENP Entry into the national phase

Ref document number: 2657165

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2007812988

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2007275410

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2009520945

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2007275410

Country of ref document: AU

Date of ref document: 20070716

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: RU

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载